查看購物車
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1962955

病理學的未來：自動化平台、數位成像和市場動態（第三版）

The Future of Pathology: Automated Platforms, Digital Imaging, and Market Dynamics, 3rd Edition
出版日期: | 出版商: Kalorama Information | 英文 120 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

病理學在現代臨床診斷中仍然至關重要，它提供細胞、組織和器官層面的洞察，指導疾病檢測、治療選擇和患者管理。隨著醫療保健越來越依賴數據和個人化，病理學的價值也不斷增長。影像、染色和分子技術的進步正在加深我們對組織結構變化如何與疾病進展相關的理解。同時，不斷增長的檢測量和實驗室數量迫使它們重新思考自身的運作方式。由 Karaorama Information 出版的 "病理學的未來：自動化平台、數位影像和市場動態" （第三版）涵蓋了這些市場趨勢及更多內容，並對 2025 年至 2030 年進行了估算和預測。

科技、工作流程與精準醫療塑造市場

該領域正朝著提高診斷準確性、改善可重複性和簡化操作的解決方案發展。 推動這項變革的關鍵因素包括：

  • 對標準化、高通量病理工作流程的需求日益增長
  • 腫瘤學和精準醫學應用的重要性日益凸顯
  • 基於組織的生物標記分析和多重檢測的廣泛應用
  • 疾病定量化、資料豐富解讀的趨勢
  • 病理學發現與更廣泛的臨床系統日益融合

因此，數位病理學、自動化染色平台和人工智慧驅動的影像分析技術在各種規模的實驗室中變得越來越普遍。這些創新能夠更快地處理複雜樣本，擴大偵測能力，並實現更一致的解讀。它們還加強了組織病理學和體外診斷之間的合作，從而能夠將病理數據更深入地整合到癌症治療過程中。

研究範圍

本報告對全球病理市場進行了全面分析，涵蓋八大主要細分市場：

  • 傳統非巴氏染色
  • 巴氏抹片檢查
  • 原位雜交
  • 免疫組織化學
  • HPV檢測
  • 循環腫瘤細胞
  • 流式細胞儀
  • 數位病理

本報告提供了2025年和2030年各製造商層面的市場估算和預測，包括複合年增長率（CAGR）。該報告還涵蓋了北美、歐洲、亞太地區和世界其他地區的區域評估，以及2025年的競爭分析。這些估算和預測是基於廣泛的一手和二手研究，包括對行業專家、公司代表、醫療保健提供者和政府官員的訪談。

預計市場將迎來顯著成長

歷史悠久的病理學市場依然充滿活力，潛力巨大。多重檢測技術、自動化和數位化分析的創新正在拓展診斷能力，提高工作流程效率，並為更深入的臨床整合創造機會。 隨著科技進步和全球市場的持續擴張，病理學市場預計在2030年後繼續發展。

目錄

第一章：摘要整理

第二章：市場概覽

  • 體外診斷病理學概覽
    • 組織學
    • 細胞學
    • 數位病理學
  • 病理與癌症
  • 先進分析解決方案
  • 實驗室自建檢測
    • 病理學臨床檢測的開發
  • 人工智慧與病理學

第三章：巴氏抹片檢查：市場規模與成長

  • 概覽
  • 市場摘要
    • 區域市場概覽

第四章：原位雜交：市場規模與成長

  • 概述
  • 市場概要
    • 區域市場概覽

第五章：免疫組織化學：市場規模與成長

  • 概述
  • 市場概要
    • 區域市場概覽

第六章：人類乳突病毒 (HPV)：市場規模與成長

  • 概述
  • 市場概要
    • 區域市場概覽

第七章：循環腫瘤細胞 (CTCS)：市場規模與成長

  • 概述
  • 市場概要
    • 區域市場概覽

第八章 流式細胞儀：市場規模與成長

  • 概述
  • 市場概要
    • 區域市場概覽

第九章 傳統非巴氏組織學染色：市場規模與成長

  • 概述
  • 市場概要
    • 區域市場概覽

第十章 數位病理：市場規模與成長

  • 概述
    • 元件概述
    • 數位病理軟體
    • 數位病理掃描儀
    • 明場掃描儀
    • 螢光掃描儀
    • 全玻片掃描儀
    • A.美納里尼診斷
    • Huron 數位病理
    • 珀金埃爾默
    • 數位病理通信與存儲
  • 應用
    • 用於精準醫療的數位病理
    • 用於科學研究與教育的數位病理
    • 用於疾病診斷的數位病理
    • 醫院
    • 診斷實驗室
    • 疫情後恢復正常
    • 門診診所
    • 數位病理的其他領域（研究）
    • 生物技術和製藥
    • 教育與研究
  • 市場概覽
    • 區域市場概覽

第11章 體外診斷病理市場概況

  • 依細分市場劃分的體外診斷病理市場概覽
  • 依細分市場劃分的體外診斷病理市場區域
  • [亞太地區、歐洲、北美、世界其他地區]
    • 北美
    • 歐洲
    • 亞太地區
    • 世界其他地區
  • 依國家劃分
  • COVID-19 對體外診斷病理學的影響（2018-2030 年）
  • 競爭分析
    • 體外診斷病理學領域四大競爭對手
    • 羅氏
    • 貝克頓‧迪金森 (BD)
    • 安捷倫
    • 丹納赫
  • 體外診斷病理學的商業前景
簡介目錄
Product Code: 26-035KA

Pathology remains fundamental to modern clinical diagnostics, supplying the cellular, tissue, and organ level insights that guide disease detection, treatment selection, and patient management. As healthcare becomes more data driven and personalized, the value of pathology continues to increase. Advances in imaging, staining, and molecular techniques have improved understanding of how structural changes in tissues relate to disease progression, while rising testing volumes and workforce shortages are prompting laboratories to reassess how they operate. The Future of Pathology: Automated Platforms, Digital Imaging, and Market Dynamics, 3rd Edition by Kalorama Information covers these market trends and more with estimates and forecasts spanning 2025-2030.

A Market Shaped by Technology, Workflows, and Precision Medicine

The field is evolving toward solutions that strengthen diagnostic accuracy, improve reproducibility, and streamline operations. Several forces are driving this shift:

  • Growing need for standardized, high volume pathology workflows
  • Rising importance of oncology and precision medicine applications
  • Expanding use of tissue based biomarker analysis and multiplex assays
  • Movement toward quantitative and data rich interpretation of disease
  • Increasing integration of pathology findings into broader clinical systems

As a result, digital pathology, automated staining platforms, and artificial intelligence enabled image analytics are gaining traction across laboratories of all sizes. These innovations allow faster turnaround, expanded testing capacity, and more consistent interpretation of complex specimens. They also strengthen the link between anatomic pathology and in vitro diagnostics, enabling deeper incorporation of pathology data into cancer care pathways.

Scope of the Report

This Kalorama Information report provides a comprehensive analysis of the global pathology market across eight major segments:

  • Traditional non PAP stains
  • PAP tests
  • In situ hybridization
  • Immunohistochemistry
  • HPV testing
  • Circulating tumor cells
  • Flow cytometry
  • Digital pathology

Market estimates are provided at the manufacturer level for 2025 and 2030, including compound annual growth rates. Competitive analysis is included for 2025, along with regional assessments covering North America, Europe, Asia Pacific, and the Rest of the World. Estimates and forecasts were developed through extensive primary and secondary research including interviews with industry experts, company personnel, healthcare providers, and government officials.

A Market Positioned for Significant Growth

Despite its long history, pathology remains a dynamic market with substantial potential. Innovations in multiplexing, automation, and digital analysis are expanding diagnostic capability, improving workflow efficiency, and opening opportunities for deeper clinical integration. With continued technological progress and global expansion, the pathology market is poised for ongoing evolution through 2030 and beyond.

TABLE OF CONTENTS

CHAPTER 1: EXECUTIVE SUMMARY

  • ABOUT KALORAMA INFORMATION
  • INDUSTRY AT A GLANCE
  • SCOPE AND METHODOLOGY
  • SIZE AND GROWTH OF THE MARKET
    • Figure 1-1: Global Pathology IVD Market, 2025-2030 ($ million)
  • COMPETITIVE OUTLOOK

CHAPTER 2: MARKET OVERVIEW

  • OVERVIEW OF IVD PATHOLOGY
    • Histology
    • Cytology
    • Digital Pathology
  • PATHOLOGY AND CANCER
  • ADVANCED ANALYSIS SOLUTIONS
    • Table 2-1: Selected Advanced Pathology Techniques
  • LABORATORY DEVELOPED TESTS
    • Laboratory Developed Tests in Pathology
  • AI AND PATHOLOGY

CHAPTER 3: PAP TESTS: MARKET SIZE AND GROWTH

  • OVERVIEW
    • Table 3-1: Primary and Secondary Prevention of Cervical Cancer, Screening Responses by Country, 2022
  • MARKET SUMMARY
    • Table 3-2: Global PAP Test Market Trend, 2020, 2025, 2030 ($ million)
    • Figure 3-1: Global PAP Test Market Trend, 2020, 2025, 2030 ($ million)
    • Regional Market Overview
      • Table 3-3: Global PAP Test Market, by Region, 2025-2030 ($ million) [Asia Pacific, Europe, North America, ROW]
      • Figure 3-2: Global PAP Test Market, by Region, 2025-2030 ($ million) [Asia Pacific, Europe, North America, RoW]

CHAPTER 4: IN SITU HYBRIDIZATION: MARKET SIZE AND GROWTH

  • OVERVIEW
    • Figure 4-1: In Situ Hybridization Indication Distribution, 2025 (%) [Oncology, Other]
    • Table 4-1: Selected in Situ Hybridization-based Tests
  • MARKET SUMMARY
    • Table 4-2: Global In Situ Hybridization Test Market Trend, 2020, 2025, 2030 ($ million)
    • Figure 4-2: Global In Situ Hybridization Test Market Trend, 2020, 2025, 2030 ($ million)
    • Regional Market Overview
      • Table 4-3: Global In Situ Hybridization IVD Test Market, by Region, 2025-2030 ($ million) [Asia Pacific, Europe, North America, RoW]
      • Figure 4-3: Global In Situ Hybridization IVD Test Market, by Region, 2025-2030 [Asia Pacific, Europe, North America, RoW]

CHAPTER 5: IMMUNOHISTOCHEMISTRY: MARKET SIZE AND GROWTH

  • OVERVIEW
    • Figure 5-1: Immunohistochemistry Distribution, by Product Type, 2025 (%) [Equipment & Instruments, Reagents]
    • Table 5-1: Selected IHC Test Innovations
  • MARKET SUMMARY
    • Table 5-2: Global Immunohistochemistry Test Market Trend, 2020, 2025, 2030 ($ million)
    • Figure 5-2: Global Immunohistochemistry Test Market Trend, 2020, 2025, 2030 ($ million)
    • Regional Market Overview
      • Table 5-3: Global Immunohistochemistry Test Market, by Region, 2025-2030 ($ million) [Asia Pacific, Europe, North America, RoW]
      • Figure 5-3: Global Immunohistochemistry Test Market, by Region, 2025-2030 ($ million) [Asia Pacific, Europe, North America, RoW]

CHAPTER 6: HUMAN PAPILLOMAVIRUS (HPV): MARKET SIZE AND GROWTH

  • OVERVIEW
    • Figure 6-1: HPV Screening Market: HPV DNA/RNA and Pap Test Distribution of Sales, 2025 (%)
    • Table 6-1: Selected HPV Test Innovations
  • MARKET SUMMARY
    • Table 6-2: Global HPV (DNA/RNA) Test Market Trend, 2020, 2025, 2030 ($ million)
    • Figure 6-2: Global HPV (DNA/RNA) Test Market Trend, 2020, 2025, 2030 ($ million)
    • Regional Market Overview
      • Table 6-3: Global HPV (DNA/RNA) Test Market, by Region, 2025-2030 ($ million) [Asia Pacific, Europe, North America, RoW]
      • Figure 6-3: Global HPV (DNA/RNA) Test Market, by Region, 2025-2030 ($ million) [Asia Pacific, Europe, North America, RoW]

CHAPTER 7: CIRCULATING TUMOR CELLS (CTCS): MARKET SIZE AND GROWTH

  • OVERVIEW
    • Table 7-1: Selected CTC Test Innovations
  • MARKET SUMMARY
    • Figure 7-1: Circulating Tumor Cells (CTCs) Distribution, by Product Type, 2025 (%) [Consumables/Reagents, Equipment and Instruments]
    • Table 7-2: Global Circulating Tumor Cells (CTCs) Test Market Trend, 2020, 2025, 2030 ($ million)
    • Figure 7-2: Global Circulating Tumor Cells (CTCs) Test Market Trend, 2020, 2025, 2030 ($ million)
    • Regional Market Overview
      • Table 7-3: Global Circulating Tumor Cells (CTCs) IVD Test Market, by Region, 2025-2030 ($ million) [Asia Pacific, Europe, North America, RoW]
      • Figure 7-3: Global Circulating Tumor Cells (CTCs) Test Market, by Region, 2025-2030 ($ million) [Asia Pacific, Europe, North America, RoW]

CHAPTER 8: FLOW CYTOMETRY: MARKET SIZE AND GROWTH

  • OVERVIEW
    • Table 8-1: Selected Flow Cytometry Innovations
  • MARKET OVERVIEW
    • Table 8-2: Global Flow Cytometry Test Market Trend, 2020, 2025, 2030 ($ million)
    • Figure 8-1: Global Flow Cytometry Test Market Trend, 2020, 2025, 2030 ($ million)
    • Regional Market Overview
      • Table 8-3: Global Flow Cytometry Test Market, by Region, 2025-2030 ($ million) [Asia Pacific, Europe, North America, RoW]
      • Figure 8-2: Global Flow Cytometry Test Market, by Region, 2025-2030 ($ million) [Asia Pacific, Europe, North America, RoW]

CHAPTER 9: TRADITIONAL NON-PAP TISSUE STAINS: MARKET SIZE AND GROWTH

  • OVERVIEW
    • Table 9-1: Selected Traditional Tissue Stain Test Innovations
    • Table 9-2: Selected Vendors of Traditional Pathology Stains
  • MARKET SUMMARY
    • Table 9-3: Global Traditional non-Pap Tissue Stains Test Market Trend, 2020, 2025, 2030 ($ million)
    • Figure 9-1: Global Traditional non-Pap Tissue Stains Test Market Trend, 2020, 2025, 2030 ($ million)
    • Regional Market Overview
      • Table 9-4: Global Traditional non-Pap Tissue Stains Test Market, by Region, 2025-2030 ($ million) [Asia Pacific, Europe, North America, RoW]
      • Figure 9-2: Global Traditional non-Pap Tissue Stains Test Market, by Region, 2025-2030 ($ million) [Asia Pacific, Europe, North America, RoW]

CHAPTER 10: DIGITAL PATHOLOGY: MARKET SIZE AND GROWTH

  • OVERVIEW
    • Component Overview
    • Digital Pathology Software
    • Digital Pathology Scanners
    • Brightfield
    • Fluorescence
    • Whole Slide Imaging
    • A. Menarini Diagnostics
    • Huron Digital Pathology
    • PerkinElmer
    • Digital Pathology Communication and Storage
    • Table 10-1: Selected Digital Pathology Innovations
  • APPLICATIONS
    • Digital Pathology for Precision Medicine
    • Digital Pathology for Research and Education
    • Digital Pathology for Disease Diagnostics
    • Hospitals
    • Diagnostic Laboratories
    • Post-Pandemic Normalization
    • Outpatient Clinics
    • Other Areas of Digital Pathology (Research Applications)
    • Biotech and Pharmaceutical Applications
    • Education and Research Applications
  • MARKET SUMMARY
    • Table 10-2: Digital Pathology Markets, by Component, 2025 ($ million) [Clinical Support Services, Hardware, Software]
    • Figure 10-1: Digital Pathology Markets, by Component, 2025 (%) [Clinical Support Services, Hardware, Software]
    • Table 10-3: Global Digital Pathology Test Market Trend, 2020, 2025, 2030 ($ million)
    • Figure 10-2: Global Digital Pathology Test Market Trend, 2020, 2025, 2030 ($ million)
    • Regional Market Overview
      • Table 10-4: Global Digital Pathology Test Market, by Region, 2025-2030 ($ million) [Asia Pacific, Europe, North America, RoW]
      • Figure 10-3: Global Digital Pathology Test Market, by Region, 2025-2030 ($ million) [Asia Pacific, Europe, North America, RoW]

CHAPTER 11: TOTAL IVD PATHOLOGY MARKET

  • Table 11-1: Total IVD Pathology Market, Sales and Market Share by Segment, ($ million) (%) 2025-20230 [Circulating Tumor Cells (CTCs), Digital Pathology, Flow Cytometry, HPV-DNA, Immunohistochemistry, in situ Hybridization, Pap Tests, Traditional non-Pap Stains]
  • Figure 11-1: Total Global IVD Pathology Market, 2020-2030 ($ million)
  • TOTAL IVD PATHOLOGY MARKET BY SEGMENT
    • Figure 11-2: Global IVD Pathology Market, by Segment Distribution, 2025 (%) [Circulating Tumor Cells (CTCs), Digital Pathology, Flow Cytometry, HPV-DNA, Immunohistochemistry, in situ Hybridization, Pap Tests, Traditional non-Pap Stains]
    • Figure 11-3: Total IVD Pathology Annual Growth, by Segment, 2020-2030 (%) [Circulating Tumor Cells (CTCs), Digital Pathology, Flow Cytometry, HPV-DNA, Immunohistochemistry, in situ Hybridization, Pap Tests, Traditional non-Pap Stains]
  • IVD PATHOLOGY MARKET BY REGION
    • Table 11-2: Global Pathology Market, by Region, 2025-2030 ($ million) [Asia Pacific, Europe, North America, RoW]
    • Figure 11-4: Global Pathology Market, by Region, 2025-2030 ($ million) [Asia Pacific, Europe, North America, RoW]
    • Table 11-3: Global Pathology Sales Distribution, by Region, 2025-2030 (%)
  • [Asia Pacific, Europe, North America, RoW]
    • North America
      • Table 11-4: North America Pathology Market, by Segment, 2025-2030 ($ million) [Circulating Tumor Cells (CTCs), Digital Pathology, Flow Cytometry, HPV-DNA, Immunohistochemistry, in situ Hybridization, Pap Tests, Traditional non-Pap Stains]
    • Europe
      • Table 11-5: Europe Pathology Market, by Segment, 2025-2030 ($ million) [Circulating Tumor Cells (CTCs), Digital Pathology, Flow Cytometry, HPV-DNA, Immunohistochemistry, in situ Hybridization, Pap Tests, Traditional non-Pap Stains]
    • Asia Pacific
      • Table 11-6: Asia Pacific Pathology Market, by Segment, 2025-2030 ($ million) [Circulating Tumor Cells (CTCs), Digital Pathology, Flow Cytometry, HPV-DNA, Immunohistochemistry, in situ Hybridization, Pap Tests, Traditional non-Pap Stains]
    • Rest of World
      • Table 11-7: Rest of World Pathology Market, by Segment, 2025-2030 ($ million) [Circulating Tumor Cells (CTCs), Digital Pathology, Flow Cytometry, HPV-DNA, Immunohistochemistry, in situ Hybridization, Pap Tests, Traditional non-Pap Stains]
  • COUNTRY DISTRIBUTION
    • Figure 11-5: Total Global IVD Pathology Market Share, by Country, 2025 (%) [Australia, Canada, China, France, Germany, Italy, Japan, Spain, United Kingdom, United States, RoW]
  • IVD PATHOLOGY COVID-19 IMPACT 2018-2030
    • Historical
    • The COVID-19 Era
    • Post-COVID-19 IVD Pathology
    • Future IVD Pathology
      • Figure 11-6: COVID-19 Pandemic Impact on the IVD Pathology Market, 2018-2030 (%)
  • COMPETITIVE ANALYSIS
    • Table 11-8: Revenues of the Major Pathology Companies, 2020-2025 ($ million)
    • Figure 11-7: Global IVD Pathology Competitive Summary, 2025 (%)
    • Top Four IVD Pathology Competitors
    • Roche
      • Table 11-9: Pathology Launches by Roche
    • Beckton Dickinson (BD)
    • Agilent
    • Danaher
  • THE COMMERCIAL OUTLOOK FOR IVD PATHOLOGY